OmniAb (OABI) Q3 Results Keep Cash Progress In Focus
OmniAb: A Self-Funding Option Book On 433 Partner Programs
OmniAb (OABI) Q3 2026 Earnings Call Transcript
OmniAb Q3 2026 Earnings Call Transcript
OmniAb Q3 Earnings Call Highlights
OmniAb, Inc. (OABI) Q3 2026 Earnings Call Transcript
OmniAb Inc. (NASDAQ:OABI) Q3 2026 Revenue Beat and Raised Guidance Offset by Sell-the-News Pressure
OmniAb, Inc. (OABI) Reports Q3 Loss, Tops Revenue Estimates
OmniAb Reports Third Quarter 2026 Financial Results and Business Highlights
OmniAb Q3 EPS $(0.12), Inline, Sales $3.993M Beat $3.492M Estimate
OmniAb Raises FY2026 Sales Guidance from $32.000M-$36.000M to $35.000M-$39.000M vs $35.036M Est
OmniAb to Participate in Upcoming Investor Conferences in November
OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference
OmniAb to Report Third Quarter 2026 Financial Results on October 30
OmniAb Investor Day Spotlights Royalty Pipeline, OmniTides Launch and xPloration Growth
OmniAb, Inc. (OABI) Analyst/Investor Day Transcript
All You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to Buy
OmniAb, Inc. (OABI) Analyst/Investor Day - Slideshow
OmniAb Highlights Partner Pipeline, xPloration® Plans and Outlook, and Introduces the OmniTides™ Platform at Investor & Analyst Day
OmniAb to Host Investor & Analyst Day on October 6, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.